Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Abiraterone Epoxide Impurity

● Auf Lager

Katalog-Nr.::	VL830017
CAS-Nr.::	N/A
Summenformel::	C26H33NO3
Molare Masse::	407.55 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Abiraterone Epoxide Impurity

Parent drug

Abiraterone

IUPAC-Name

(4S, 6aR, 6bS, 8aS, 8bR, 9aR, 10aS, 10bR)-6a, 8a-dimethyl-8b-(pyridin-3-yl)-3, 4, 5, 6, 6a, 6b, 7, 8, 8a, 8b, 9a, 10, 10a, 10b-tetradecahydro-1H-naphtho[2′, 1′:4, 5]indeno[1, 2-b]oxiren-4-yl acetate

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

CC(O[C@@H](CC[C@@]12C)CC1=CC[C@@]([C@]2([H])CC[C@@]34C)([H])[C@]3([H])C[C@]5([H])[C@@]4(C6=CC=CN=C6)O5)=O

InChI

InChI=1S/C26H33NO3/c1-16(28)29-19-8-10-24(2)17(13-19)6-7-20-21(24)9-11-25(3)22(20)14-23-26(25,30-23)18-5-4-12-27-15-18/h4-6,12,15,19-23H,7-11,13-14H2,1-3H3/t19-,20+,21-,22-,23+,24-,25-,26+/m0/s1

Beschreibung

The compound Abiraterone Epoxide Impurity is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. Abiraterone Epoxide Impurity or alpha-Epoxy Abiraterone Acetate is an impurity of Abiraterone acetate which is a derivative of steroidal progesterone designated for use in conjunction with castration and prednisone for the treatment of metastatic castration and the treatment of metastatic high-risk castration sensitive prostate cancer.

References

Kavitapu, DasameswaraRao, et al. â€œNew Stability Indicating RP-HPLC Method for the Determination of Abiraterone Acetate, Its Related Substances and Degradation Products in Bulk and Dosage Form.â€Â Materials Today: Proceedings, vol. 34, 2021, pp. 469â€“78, https://doi.org/10.1016/j.matpr.2020.02.665.